期刊
ANTIVIRAL THERAPY
卷 16, 期 2, 页码 253-256出版社
INT MEDICAL PRESS LTD
DOI: 10.3851/IMP1748
关键词
-
资金
- Bristol-Myers Squibb
- Cerner Corporation
- Gilead Sciences
- Merck
- Roche
- GlaxoSmithKline
- Boehringer Ingelheim
We report the case of an integrase strand-transfer inhibitor (INI)-resistant and four-drug-class-resistant HIV-1 variant infecting an antiretroviral therapy-naive man. The virus harboured INI drug resistance substitutions (Q148H and G140S) along with multiple reverse transcriptase and protease inhibitor resistance mutations. This case illustrates an emerging need to consider the possibility of acquired INI resistance among newly diagnosed treatment-naive individuals harbouring multidrug-resistant HIV-1.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据